Lime Technologies AB (publ) (LIME)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 259.50 |
|---|---|
| 52-week range | 175.23 – 366.76 |
| Return, 1 month / 3 months | +7.2% / +24.5% |
| Return, 1 year / 3 years | −14.1% / −2.5% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 48.3% |
| Worst drawdown (1 year) | -51.2% |
| Average daily value traded | 8.13M SEK |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lime Technologies AB is a Swedish software company based in Lund that develops and supplies business systems, chiefly customer relationship management software, to small and medium-sized organisations. Its main offering, Lime CRM, helps companies organise customer contacts, sales work and service cases, and the firm also provides related consulting, implementation and support services. Customers come from many industries across the Nordic region and beyond, and the software is delivered as a subscription service.
The shares are listed on the Stockholm Exchange in Sweden under the code LIME, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lime Technologies AB (publ) (LIME) trades on the Stockholm Exchange in Sweden. It last closed at SEK 259.50 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 298 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.1% and over the last three months it rose 24.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.4% | ||
| From 52-week high | -28.2% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 24.5% | ||
| 6-month return | 15.0% | ||
| 12-month return, skipping the last month | -19.9% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.2% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 8.13M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +7.2% |
| 3 months | +24.5% |
| 6 months | +15.0% |
| 1 year | −14.1% |
| 3 years | −2.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 245.22 / 224.96 |
|---|---|
| Golden / death cross (60 days) | Golden, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | SEK 2.2500 |
| 31 Oct 2025 | SEK 2.0000 |
| 2 May 2025 | SEK 2.0000 |
| 28 Oct 2024 | SEK 1.7500 |
| 26 Apr 2024 | SEK 1.7500 |
| 27 Apr 2023 | SEK 2.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.